Staar Surgical Co

STAA

Equity

ISIN null / Valor 972813

NASDAQ (2025-11-21)

USD 28.00+2.38%

Staar Surgical Co
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

STAAR Surgical Co. is a company that has been focused on ophthalmic surgery for over 30 years, specializing in designing, developing, manufacturing, and marketing implantable lenses for the eye with companion delivery systems. These lenses, including the Implantable Collamer® Lens (ICL) and various models of Collamer® and Preloaded IOLs, are foldable, allowing for insertion through a small incision. The company's products aim to provide visual freedom for patients by reducing or eliminating the need for glasses or contact lenses. With over 900 employees, STAAR markets its lenses in more than 75 countries, with millions of lenses sold worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Double-Digit Sales Growth

STAAR achieved double-digit year-over-year growth in Implantable Collamer Lens (ICL) sales globally during fiscal 2024, with the exception of the China market.

Technological Leadership

The company's industry-leading EVO ICL technology played a crucial role in driving sales growth and expanding its market presence.

Earnings Conference Call Scheduled

STAAR Surgical will host its fourth quarter and fiscal year 2024 earnings conference call and webcast on February 19, 2025, to discuss detailed financial results and operational progress.

Summarized from source with an LLMView Source

Key figures

5.14%1Y

-53.2%3Y

-65.9%5Y

Performance

68.0%1Y

60.7%3Y

61.7%5Y

Volatility